Back to news list

Information Sessions - Demineralized Bone Matrices (DBM)

There have been certain changes to our offer of demineralized bone matrices (DBM) products since our sole human tissue distributor mandate came into effect on December 2, 2024. We have identified a need for training on this product family, based on the preliminary data we gathered on distribution trends since the mandate has come into effect, and on conversations with some of our consultants.

To address this need, Héma-Québec has put together a series of information sessions on DBM products, in collaboration with LifeNet Health (February 24 and 25, 2025) and Bioventus, for the OsteoAMP line (March 19 and 20, 2025).

These sessions were developed to help participants better understand our products and to present the products introduced to Québec (LifeNet Health) since our sole distributor mandate took effect. Héma-Québec also wanted to understand how we can support the healthcare system in a needs-based approach to selecting these products.

These sessions were an invaluable opportunity to ask questions and talk to our team of experts. You can watch the LifeNet Health DBM information session, in French only, to learn more.